mouse igg Search Results


91
R&D Systems rabbit anti mouse rantes immunoglobulin g igg
Proposed mechanism of SP600125-mediated suppression of nicotine-related AAA in the C57BL/6J mouse model. AngII, angiotensin II; JNK, c-Jun N-terminal kinase; MCP-1, monocyte chemoattractant protein-1; <t>RANTES,</t> regulated-on-activation, normal T-cell expressed and secreted; MMP, matrix metalloproteinase; ECM, extracellular matrix.
Rabbit Anti Mouse Rantes Immunoglobulin G Igg, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti mouse rantes immunoglobulin g igg/product/R&D Systems
Average 91 stars, based on 1 article reviews
rabbit anti mouse rantes immunoglobulin g igg - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

91
Novus Biologicals fitc goat anti mouse secondary antibodies
Proposed mechanism of SP600125-mediated suppression of nicotine-related AAA in the C57BL/6J mouse model. AngII, angiotensin II; JNK, c-Jun N-terminal kinase; MCP-1, monocyte chemoattractant protein-1; <t>RANTES,</t> regulated-on-activation, normal T-cell expressed and secreted; MMP, matrix metalloproteinase; ECM, extracellular matrix.
Fitc Goat Anti Mouse Secondary Antibodies, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc goat anti mouse secondary antibodies/product/Novus Biologicals
Average 91 stars, based on 1 article reviews
fitc goat anti mouse secondary antibodies - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

96
R&D Systems haf007 rrid ab 357234
Proposed mechanism of SP600125-mediated suppression of nicotine-related AAA in the C57BL/6J mouse model. AngII, angiotensin II; JNK, c-Jun N-terminal kinase; MCP-1, monocyte chemoattractant protein-1; <t>RANTES,</t> regulated-on-activation, normal T-cell expressed and secreted; MMP, matrix metalloproteinase; ECM, extracellular matrix.
Haf007 Rrid Ab 357234, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/haf007 rrid ab 357234/product/R&D Systems
Average 96 stars, based on 1 article reviews
haf007 rrid ab 357234 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

95
R&D Systems rabbit anti mouse ifnβ detection antibody
Proposed mechanism of SP600125-mediated suppression of nicotine-related AAA in the C57BL/6J mouse model. AngII, angiotensin II; JNK, c-Jun N-terminal kinase; MCP-1, monocyte chemoattractant protein-1; <t>RANTES,</t> regulated-on-activation, normal T-cell expressed and secreted; MMP, matrix metalloproteinase; ECM, extracellular matrix.
Rabbit Anti Mouse Ifnβ Detection Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti mouse ifnβ detection antibody/product/R&D Systems
Average 95 stars, based on 1 article reviews
rabbit anti mouse ifnβ detection antibody - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

93
R&D Systems mouse igg2a
Proposed mechanism of SP600125-mediated suppression of nicotine-related AAA in the C57BL/6J mouse model. AngII, angiotensin II; JNK, c-Jun N-terminal kinase; MCP-1, monocyte chemoattractant protein-1; <t>RANTES,</t> regulated-on-activation, normal T-cell expressed and secreted; MMP, matrix metalloproteinase; ECM, extracellular matrix.
Mouse Igg2a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse igg2a/product/R&D Systems
Average 93 stars, based on 1 article reviews
mouse igg2a - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

94
R&D Systems apc conjugated goat anti mouse igg antibody
Proposed mechanism of SP600125-mediated suppression of nicotine-related AAA in the C57BL/6J mouse model. AngII, angiotensin II; JNK, c-Jun N-terminal kinase; MCP-1, monocyte chemoattractant protein-1; <t>RANTES,</t> regulated-on-activation, normal T-cell expressed and secreted; MMP, matrix metalloproteinase; ECM, extracellular matrix.
Apc Conjugated Goat Anti Mouse Igg Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc conjugated goat anti mouse igg antibody/product/R&D Systems
Average 94 stars, based on 1 article reviews
apc conjugated goat anti mouse igg antibody - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

92
R&D Systems mouse isotype control antibody
Proposed mechanism of SP600125-mediated suppression of nicotine-related AAA in the C57BL/6J mouse model. AngII, angiotensin II; JNK, c-Jun N-terminal kinase; MCP-1, monocyte chemoattractant protein-1; <t>RANTES,</t> regulated-on-activation, normal T-cell expressed and secreted; MMP, matrix metalloproteinase; ECM, extracellular matrix.
Mouse Isotype Control Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse isotype control antibody/product/R&D Systems
Average 92 stars, based on 1 article reviews
mouse isotype control antibody - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

94
R&D Systems α mouse igg nl493
Proposed mechanism of SP600125-mediated suppression of nicotine-related AAA in the C57BL/6J mouse model. AngII, angiotensin II; JNK, c-Jun N-terminal kinase; MCP-1, monocyte chemoattractant protein-1; <t>RANTES,</t> regulated-on-activation, normal T-cell expressed and secreted; MMP, matrix metalloproteinase; ECM, extracellular matrix.
α Mouse Igg Nl493, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/α mouse igg nl493/product/R&D Systems
Average 94 stars, based on 1 article reviews
α mouse igg nl493 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

90
R&D Systems mouse igg2 b anti human tigit
Proposed mechanism of SP600125-mediated suppression of nicotine-related AAA in the C57BL/6J mouse model. AngII, angiotensin II; JNK, c-Jun N-terminal kinase; MCP-1, monocyte chemoattractant protein-1; <t>RANTES,</t> regulated-on-activation, normal T-cell expressed and secreted; MMP, matrix metalloproteinase; ECM, extracellular matrix.
Mouse Igg2 B Anti Human Tigit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse igg2 b anti human tigit/product/R&D Systems
Average 90 stars, based on 1 article reviews
mouse igg2 b anti human tigit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

95
R&D Systems mouse immunoglobulin g irrelevant isotype control
Proposed mechanism of SP600125-mediated suppression of nicotine-related AAA in the C57BL/6J mouse model. AngII, angiotensin II; JNK, c-Jun N-terminal kinase; MCP-1, monocyte chemoattractant protein-1; <t>RANTES,</t> regulated-on-activation, normal T-cell expressed and secreted; MMP, matrix metalloproteinase; ECM, extracellular matrix.
Mouse Immunoglobulin G Irrelevant Isotype Control, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse immunoglobulin g irrelevant isotype control/product/R&D Systems
Average 95 stars, based on 1 article reviews
mouse immunoglobulin g irrelevant isotype control - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

95
R&D Systems mouse igg1 control
HIV-induced BC expression of IL-8 mediates AM and neutrophil migration. BC were exposed to HIV or heat-inactivated HIV for 2 days. ( A ) Quantification of IL-8 in culture supernatants of untreated, heat-inactivated HIV and HIV- treated BC cultures by ELISA. ( B ) HIV-induced BC release of these mediators induce migration of human alveolar macrophages and neutrophils. Alveolar macrophages obtained from an HIV negative normal subject were plated in serum-free medium in the upper chamber and incubated with BC-conditioned media from untreated, NL4-3 treated and heat-inactivated NL4-3-treated BC culture in the lower chamber of transwell system. The number of migratory cells were quantified after 3 h. ( C ) Migration of human alveolar macrophages mediated by BC-release of IL-8. BC-conditioned media were pre-treated with mouse <t>IgG1</t> control or anti-IL-8 neutralizing antibody (both at 2 µg/ml) for 30 min prior to addition to the lower chamber. Human alveolar macrophages were plated on the upper chamber and incubated with conditioned media from untreated BC, HIV-BC pretreated with mouse IgG 1 -treated or HIV-BC pretreated with anti-IL-8 neutralizing antibody. The number of migratory alveolar macrophages were counted after 3 h. Data shown are the mean ± SD of one representative of three independent experiments performed in triplicate. ( D ) Stimulation of migration of neutrophils. Human neutrophils in serum-free RPMI were plated in the upper chamber and incubated with BC-conditioned media from untreated, HIV-treated and heat-inactivated HIV-treated BC culture in the lower chamber of transwell system. The number of migratory cells were quantified after 1 h of incubation. ( E ) Migration of human neutrophils mediated by BC-released IL-8 in conditioned media. BC-conditioned media were pre-treated with mouse IgG 1 control and anti-IL-8 neutralizing antibody (both at 2 µg/ml) for 30 min prior to addition to the lower chamber. Human neutrophils were plated on the upper chamber and incubated with conditioned media from untreated BC, HIV-BC pretreated with mouse IgG 1 -treated, HIV-BC pretreated with anti-IL-8 neutralizing antibody or HIV-treated BC. The number of migratory alveolar macrophages were counted after 1 h of incubation. Data are presented as mean ± SD of one representative of three independent experiments performed in triplicate.
Mouse Igg1 Control, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse igg1 control/product/R&D Systems
Average 95 stars, based on 1 article reviews
mouse igg1 control - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

95
R&D Systems mouse igg2a isotype control antibody
HIV-induced BC expression of IL-8 mediates AM and neutrophil migration. BC were exposed to HIV or heat-inactivated HIV for 2 days. ( A ) Quantification of IL-8 in culture supernatants of untreated, heat-inactivated HIV and HIV- treated BC cultures by ELISA. ( B ) HIV-induced BC release of these mediators induce migration of human alveolar macrophages and neutrophils. Alveolar macrophages obtained from an HIV negative normal subject were plated in serum-free medium in the upper chamber and incubated with BC-conditioned media from untreated, NL4-3 treated and heat-inactivated NL4-3-treated BC culture in the lower chamber of transwell system. The number of migratory cells were quantified after 3 h. ( C ) Migration of human alveolar macrophages mediated by BC-release of IL-8. BC-conditioned media were pre-treated with mouse <t>IgG1</t> control or anti-IL-8 neutralizing antibody (both at 2 µg/ml) for 30 min prior to addition to the lower chamber. Human alveolar macrophages were plated on the upper chamber and incubated with conditioned media from untreated BC, HIV-BC pretreated with mouse IgG 1 -treated or HIV-BC pretreated with anti-IL-8 neutralizing antibody. The number of migratory alveolar macrophages were counted after 3 h. Data shown are the mean ± SD of one representative of three independent experiments performed in triplicate. ( D ) Stimulation of migration of neutrophils. Human neutrophils in serum-free RPMI were plated in the upper chamber and incubated with BC-conditioned media from untreated, HIV-treated and heat-inactivated HIV-treated BC culture in the lower chamber of transwell system. The number of migratory cells were quantified after 1 h of incubation. ( E ) Migration of human neutrophils mediated by BC-released IL-8 in conditioned media. BC-conditioned media were pre-treated with mouse IgG 1 control and anti-IL-8 neutralizing antibody (both at 2 µg/ml) for 30 min prior to addition to the lower chamber. Human neutrophils were plated on the upper chamber and incubated with conditioned media from untreated BC, HIV-BC pretreated with mouse IgG 1 -treated, HIV-BC pretreated with anti-IL-8 neutralizing antibody or HIV-treated BC. The number of migratory alveolar macrophages were counted after 1 h of incubation. Data are presented as mean ± SD of one representative of three independent experiments performed in triplicate.
Mouse Igg2a Isotype Control Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse igg2a isotype control antibody/product/R&D Systems
Average 95 stars, based on 1 article reviews
mouse igg2a isotype control antibody - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

Image Search Results


Proposed mechanism of SP600125-mediated suppression of nicotine-related AAA in the C57BL/6J mouse model. AngII, angiotensin II; JNK, c-Jun N-terminal kinase; MCP-1, monocyte chemoattractant protein-1; RANTES, regulated-on-activation, normal T-cell expressed and secreted; MMP, matrix metalloproteinase; ECM, extracellular matrix.

Journal: Mediators of Inflammation

Article Title: SP600125 Attenuates Nicotine-Related Aortic Aneurysm Formation by Inhibiting Matrix Metalloproteinase Production and CC Chemokine-Mediated Macrophage Migration

doi: 10.1155/2016/9142425

Figure Lengend Snippet: Proposed mechanism of SP600125-mediated suppression of nicotine-related AAA in the C57BL/6J mouse model. AngII, angiotensin II; JNK, c-Jun N-terminal kinase; MCP-1, monocyte chemoattractant protein-1; RANTES, regulated-on-activation, normal T-cell expressed and secreted; MMP, matrix metalloproteinase; ECM, extracellular matrix.

Article Snippet: Slides were incubated with rabbit anti-mouse RANTES immunoglobulin G (IgG), rabbit anti-mouse MCP-1 IgG, rabbit anti-mouse MMP-2, rabbit anti-mouse MMP-9, or reagent-grade nonimmune rat IgG (R&D Systems, Minneapolis, MN, USA) overnight at 4°C in a humidified chamber.

Techniques: Activation Assay

SP600125 suppresses the protein expression of chemokines in aortic tissue. (a) Representative transverse sections of mouse aortic tissue obtained after transient perfusion with nicotine plus AngII, with or without SP600125. MCP-1 and RANTES proteins were undetectable in normal aorta but were abundant in nicotine plus AngII-induced AAA tissues (a1 and a2), where they appear to be expressed in the medial and outer smooth muscle cells. SP600125 inhibited the protein expression of MCP-1 and RANTES in AAA lesions (a3). (c, d) Representative western blots for MCP-1 and RANTES. The band optical density (OD) values (mean ± SD) of MCP-1 and RANTES were evaluated using ImageJ. GAPDH was used as an internal control and results are from independent triplicate experiments. Chemokine expression in the serum as detected by ELISA (e). ∗∗ P < 0.01 versus coadministration.

Journal: Mediators of Inflammation

Article Title: SP600125 Attenuates Nicotine-Related Aortic Aneurysm Formation by Inhibiting Matrix Metalloproteinase Production and CC Chemokine-Mediated Macrophage Migration

doi: 10.1155/2016/9142425

Figure Lengend Snippet: SP600125 suppresses the protein expression of chemokines in aortic tissue. (a) Representative transverse sections of mouse aortic tissue obtained after transient perfusion with nicotine plus AngII, with or without SP600125. MCP-1 and RANTES proteins were undetectable in normal aorta but were abundant in nicotine plus AngII-induced AAA tissues (a1 and a2), where they appear to be expressed in the medial and outer smooth muscle cells. SP600125 inhibited the protein expression of MCP-1 and RANTES in AAA lesions (a3). (c, d) Representative western blots for MCP-1 and RANTES. The band optical density (OD) values (mean ± SD) of MCP-1 and RANTES were evaluated using ImageJ. GAPDH was used as an internal control and results are from independent triplicate experiments. Chemokine expression in the serum as detected by ELISA (e). ∗∗ P < 0.01 versus coadministration.

Article Snippet: Slides were incubated with rabbit anti-mouse RANTES immunoglobulin G (IgG), rabbit anti-mouse MCP-1 IgG, rabbit anti-mouse MMP-2, rabbit anti-mouse MMP-9, or reagent-grade nonimmune rat IgG (R&D Systems, Minneapolis, MN, USA) overnight at 4°C in a humidified chamber.

Techniques: Expressing, Western Blot, Control, Enzyme-linked Immunosorbent Assay

Expression of MCP-1 and RANTES under a concentration gradient of nicotine in MOVAS cells. Cellular mRNA expression levels of MCP-1 and RANTES (a, b) and the levels of secreted MCP-1 and RANTES in the supernatant (c, d) are shown. MCP-1 and RANTES expression as well as secretion was induced by nicotine in a dose-dependent fashion. The strongest expression was observed for 0.5 ng/mL and 5 ng/mL nicotine. Data are from independent triplicate experiments. ∗ P < 0.05 and ∗∗ P < 0.01 versus control; # P < 0.05 and ## P < 0.01 versus the group treated with 5 ng/mL nicotine.

Journal: Mediators of Inflammation

Article Title: SP600125 Attenuates Nicotine-Related Aortic Aneurysm Formation by Inhibiting Matrix Metalloproteinase Production and CC Chemokine-Mediated Macrophage Migration

doi: 10.1155/2016/9142425

Figure Lengend Snippet: Expression of MCP-1 and RANTES under a concentration gradient of nicotine in MOVAS cells. Cellular mRNA expression levels of MCP-1 and RANTES (a, b) and the levels of secreted MCP-1 and RANTES in the supernatant (c, d) are shown. MCP-1 and RANTES expression as well as secretion was induced by nicotine in a dose-dependent fashion. The strongest expression was observed for 0.5 ng/mL and 5 ng/mL nicotine. Data are from independent triplicate experiments. ∗ P < 0.05 and ∗∗ P < 0.01 versus control; # P < 0.05 and ## P < 0.01 versus the group treated with 5 ng/mL nicotine.

Article Snippet: Slides were incubated with rabbit anti-mouse RANTES immunoglobulin G (IgG), rabbit anti-mouse MCP-1 IgG, rabbit anti-mouse MMP-2, rabbit anti-mouse MMP-9, or reagent-grade nonimmune rat IgG (R&D Systems, Minneapolis, MN, USA) overnight at 4°C in a humidified chamber.

Techniques: Expressing, Concentration Assay, Control

Influence of SP600125 on nicotine-induced expression of MCP-1 and RANTES in MOVAS cells. Cellular mRNA expression levels of MCP-1 and RANTES (a, b) and the levels of secreted MCP-1 and RANTES in the supernatant (c, d) are shown. Nicotine at 5 ng/mL could significantly upregulate the cellular mRNA expression as well as secretion of MCP-1 and RANTES, while SP600125 eliminated this effect. Data are from independent triplicate experiments. ∗ P < 0.05 and ∗∗ P < 0.01 versus control; # P < 0.05 and ## P < 0.01 versus the group treated with 5 ng/mL nicotine.

Journal: Mediators of Inflammation

Article Title: SP600125 Attenuates Nicotine-Related Aortic Aneurysm Formation by Inhibiting Matrix Metalloproteinase Production and CC Chemokine-Mediated Macrophage Migration

doi: 10.1155/2016/9142425

Figure Lengend Snippet: Influence of SP600125 on nicotine-induced expression of MCP-1 and RANTES in MOVAS cells. Cellular mRNA expression levels of MCP-1 and RANTES (a, b) and the levels of secreted MCP-1 and RANTES in the supernatant (c, d) are shown. Nicotine at 5 ng/mL could significantly upregulate the cellular mRNA expression as well as secretion of MCP-1 and RANTES, while SP600125 eliminated this effect. Data are from independent triplicate experiments. ∗ P < 0.05 and ∗∗ P < 0.01 versus control; # P < 0.05 and ## P < 0.01 versus the group treated with 5 ng/mL nicotine.

Article Snippet: Slides were incubated with rabbit anti-mouse RANTES immunoglobulin G (IgG), rabbit anti-mouse MCP-1 IgG, rabbit anti-mouse MMP-2, rabbit anti-mouse MMP-9, or reagent-grade nonimmune rat IgG (R&D Systems, Minneapolis, MN, USA) overnight at 4°C in a humidified chamber.

Techniques: Expressing, Control

HIV-induced BC expression of IL-8 mediates AM and neutrophil migration. BC were exposed to HIV or heat-inactivated HIV for 2 days. ( A ) Quantification of IL-8 in culture supernatants of untreated, heat-inactivated HIV and HIV- treated BC cultures by ELISA. ( B ) HIV-induced BC release of these mediators induce migration of human alveolar macrophages and neutrophils. Alveolar macrophages obtained from an HIV negative normal subject were plated in serum-free medium in the upper chamber and incubated with BC-conditioned media from untreated, NL4-3 treated and heat-inactivated NL4-3-treated BC culture in the lower chamber of transwell system. The number of migratory cells were quantified after 3 h. ( C ) Migration of human alveolar macrophages mediated by BC-release of IL-8. BC-conditioned media were pre-treated with mouse IgG1 control or anti-IL-8 neutralizing antibody (both at 2 µg/ml) for 30 min prior to addition to the lower chamber. Human alveolar macrophages were plated on the upper chamber and incubated with conditioned media from untreated BC, HIV-BC pretreated with mouse IgG 1 -treated or HIV-BC pretreated with anti-IL-8 neutralizing antibody. The number of migratory alveolar macrophages were counted after 3 h. Data shown are the mean ± SD of one representative of three independent experiments performed in triplicate. ( D ) Stimulation of migration of neutrophils. Human neutrophils in serum-free RPMI were plated in the upper chamber and incubated with BC-conditioned media from untreated, HIV-treated and heat-inactivated HIV-treated BC culture in the lower chamber of transwell system. The number of migratory cells were quantified after 1 h of incubation. ( E ) Migration of human neutrophils mediated by BC-released IL-8 in conditioned media. BC-conditioned media were pre-treated with mouse IgG 1 control and anti-IL-8 neutralizing antibody (both at 2 µg/ml) for 30 min prior to addition to the lower chamber. Human neutrophils were plated on the upper chamber and incubated with conditioned media from untreated BC, HIV-BC pretreated with mouse IgG 1 -treated, HIV-BC pretreated with anti-IL-8 neutralizing antibody or HIV-treated BC. The number of migratory alveolar macrophages were counted after 1 h of incubation. Data are presented as mean ± SD of one representative of three independent experiments performed in triplicate.

Journal: Scientific Reports

Article Title: HIV induces airway basal progenitor cells to adopt an inflammatory phenotype

doi: 10.1038/s41598-021-82143-1

Figure Lengend Snippet: HIV-induced BC expression of IL-8 mediates AM and neutrophil migration. BC were exposed to HIV or heat-inactivated HIV for 2 days. ( A ) Quantification of IL-8 in culture supernatants of untreated, heat-inactivated HIV and HIV- treated BC cultures by ELISA. ( B ) HIV-induced BC release of these mediators induce migration of human alveolar macrophages and neutrophils. Alveolar macrophages obtained from an HIV negative normal subject were plated in serum-free medium in the upper chamber and incubated with BC-conditioned media from untreated, NL4-3 treated and heat-inactivated NL4-3-treated BC culture in the lower chamber of transwell system. The number of migratory cells were quantified after 3 h. ( C ) Migration of human alveolar macrophages mediated by BC-release of IL-8. BC-conditioned media were pre-treated with mouse IgG1 control or anti-IL-8 neutralizing antibody (both at 2 µg/ml) for 30 min prior to addition to the lower chamber. Human alveolar macrophages were plated on the upper chamber and incubated with conditioned media from untreated BC, HIV-BC pretreated with mouse IgG 1 -treated or HIV-BC pretreated with anti-IL-8 neutralizing antibody. The number of migratory alveolar macrophages were counted after 3 h. Data shown are the mean ± SD of one representative of three independent experiments performed in triplicate. ( D ) Stimulation of migration of neutrophils. Human neutrophils in serum-free RPMI were plated in the upper chamber and incubated with BC-conditioned media from untreated, HIV-treated and heat-inactivated HIV-treated BC culture in the lower chamber of transwell system. The number of migratory cells were quantified after 1 h of incubation. ( E ) Migration of human neutrophils mediated by BC-released IL-8 in conditioned media. BC-conditioned media were pre-treated with mouse IgG 1 control and anti-IL-8 neutralizing antibody (both at 2 µg/ml) for 30 min prior to addition to the lower chamber. Human neutrophils were plated on the upper chamber and incubated with conditioned media from untreated BC, HIV-BC pretreated with mouse IgG 1 -treated, HIV-BC pretreated with anti-IL-8 neutralizing antibody or HIV-treated BC. The number of migratory alveolar macrophages were counted after 1 h of incubation. Data are presented as mean ± SD of one representative of three independent experiments performed in triplicate.

Article Snippet: For blocking experiments, BC-conditioned media was pre-incubated with anti-IL-8 neutralizing antibody (clone # 6217) and corresponding mouse IgG1 control (clone # 11,711; both at 2 μg/ml, endotoxin level < 0.10 EU per 1 μg of the antibody by the LAL method; R & D Systems) for 30 min at 37 oC prior to addition to the lower chamber.

Techniques: Expressing, Migration, Enzyme-linked Immunosorbent Assay, Incubation, Control

HIV-treated BC release GM-CSF that stimulates AM proliferation. ( A) Quantification of GM-CSF in BC-conditioned medium by ELISA. ( B) Proliferation of human AM is partially mediated by BC-released GM-CSF in conditioned media. Alveolar macrophages in serum-free RPMI were plated in 96-well and incubated with BC-conditioned media from untreated, HIV-treated and heat-inactivated HIV-treated BC culture. RPMI and recombinant GM-CSF (20 ng/ml) serve as background and positive controls, respectively. BC-conditioned media were pre-treated with mouse IgG 1 control and anti-GM-CSF neutralizing antibody (both at 10 µg/ml) for 30 min prior to addition to the cells. Cell proliferation was measured by BrdU incorporation assay after 3 days of culture. Data represent the mean ± SD of one representative experiment (n = 3) performed in triplicate.

Journal: Scientific Reports

Article Title: HIV induces airway basal progenitor cells to adopt an inflammatory phenotype

doi: 10.1038/s41598-021-82143-1

Figure Lengend Snippet: HIV-treated BC release GM-CSF that stimulates AM proliferation. ( A) Quantification of GM-CSF in BC-conditioned medium by ELISA. ( B) Proliferation of human AM is partially mediated by BC-released GM-CSF in conditioned media. Alveolar macrophages in serum-free RPMI were plated in 96-well and incubated with BC-conditioned media from untreated, HIV-treated and heat-inactivated HIV-treated BC culture. RPMI and recombinant GM-CSF (20 ng/ml) serve as background and positive controls, respectively. BC-conditioned media were pre-treated with mouse IgG 1 control and anti-GM-CSF neutralizing antibody (both at 10 µg/ml) for 30 min prior to addition to the cells. Cell proliferation was measured by BrdU incorporation assay after 3 days of culture. Data represent the mean ± SD of one representative experiment (n = 3) performed in triplicate.

Article Snippet: For blocking experiments, BC-conditioned media was pre-incubated with anti-IL-8 neutralizing antibody (clone # 6217) and corresponding mouse IgG1 control (clone # 11,711; both at 2 μg/ml, endotoxin level < 0.10 EU per 1 μg of the antibody by the LAL method; R & D Systems) for 30 min at 37 oC prior to addition to the lower chamber.

Techniques: Enzyme-linked Immunosorbent Assay, Incubation, Recombinant, Control, BrdU Incorporation Assay